Michael Landis Insider Profile
4 Followers
Michael Landis, Chief Financial Officer, Director at Polaryx Therapeutics, Inc., holds 228.22K shares in Polaryx Therapeutics, Inc. (Ticker: PLYX), holds 37.69K shares in Lannett Company (Ticker: LCINQ). Most recently, Michael Landis Bought ― shares of Polaryx Therapeutics, Inc. on Feb 20, 2026 for an estimated value of $7.97K.
Michael Landis's Trading History
| PLYXPolaryx Therapeutics, Inc. | Feb 20, 2026 | Chief Financial Officer, Director | Informative Buy | 7.97K | $403.96K | |
| LCINQLannett Company | Nov 14, 2019 | ― | Uninformative Sell | 13.35K | $1.09K |
You May Also Like
Michael Landis insider profile FAQ
What is the percentage of profitable transactions made by Michael Landis?
The percentage of profitable transactions made by Michael Landis is 75%.
What is the average return per transaction made by Michael Landis?
The average return per transaction made by Michael Landis is 27.80%.
What stocks does Michael Landis hold?
Michael Landis holds: PLYX, LCINQ stocks.
What was Michael Landis’s latest transaction?
Michael Landis’s latest transaction was an Informative Buy of $7.97K.
What was Michael Landis's most profitable transaction?
Michael Landis’s most profitable transaction was an Informative Sell of LCINQ stock on February 17, 2015. The return on the trade was 56.50%.
What is Michael Landis's role in Polaryx Therapeutics, Inc.?
Michael Landis's role in Polaryx Therapeutics, Inc. is Chief Financial Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
